Sign In
Buy JNJ
$239.08
+7.79 (+3.37%)
At Close: Jun 23, 2026
Should You Buy This Dividend Aristocrat for Growing Passive Income?
02:30pm, Sunday, 28'th Aug 2022 The Motley Fool
McDonald's 2.1% dividend yield is meaningfully higher than the S&P 500 index's 1.5% yield.
Dividend Champion, Contender, And Challenger Highlights: Week Of August 28
04:23am, Sunday, 28'th Aug 2022 Seeking Alpha
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here for an update on dividend stocks for the week of Aug 28.
Worried About a Recession? Buy These 2 Warren Buffett Stocks.
01:45pm, Friday, 26'th Aug 2022 The Motley Fool
These companies are beating the market this year.
Will companies continue to raise prices to maintain their record profit margins?
01:00pm, Sunday, 17'th Jul 2022 MarketWatch
As earnings reporting season kicks into high gear, there is one major question that could determine where stock prices and inflation will head from here: Will companies continue to raise prices or cu
1 Stock To Buy, 1 Stock To Dump This Week: Johnson & Johnson, Snap
11:34am, Sunday, 17'th Jul 2022 Investing.com
3 Dividend Growth Stocks to Buy in July
09:58am, Sunday, 17'th Jul 2022 The Motley Fool
These three stocks have a lot in common.
Want to Get Richer? 5 Best Stocks to Buy Now and Hold Forever
11:15am, Saturday, 16'th Jul 2022 The Motley Fool
Health and wealth; it doesn't get much better than that.
3 Vanguard ETFs That Could Help You Retire a Millionaire
01:15pm, Friday, 15'th Jul 2022 The Motley Fool
Over the past 10 years, these have been three of the best performing Vanguard ETFs
J&J (JNJ) to Begin Pharma Sector's Q2 Earnings With a Beat?
12:17pm, Friday, 15'th Jul 2022 Zacks Investment Research
J&J's (JNJ) Pharma segment is expected to have performed above the market. In the MedTech segment, the recovery in demand trends seen in the first quarter is likely to have continued in the second.
This Stock Is Down By 13% This Year: Here's Why It's a Buy
12:05pm, Friday, 15'th Jul 2022 The Motley Fool
The market may be undervaluing this drugmaker.
Novavax's protein-based vaccine approval fails to boost stock as demand in U.S. for shots and boosters remains low
10:27am, Friday, 15'th Jul 2022 MarketWatch
U.S. health regulators authorized the use of Novavax Inc.'s COVID-19 vaccine, providing a new option that works differently than the two leading vaccines based on mRNA technology, but the move comes
Zacks Investment Ideas feature highlights: Coca-Cola, Kroger and Johnson & Johnson
10:21am, Friday, 15'th Jul 2022 Zacks Investment Research
Coca-Cola, Kroger and Johnson & Johnson are part of Zacks Investment Ideas article.
The Zacks Analyst Blog Highlights Synchrony Financial, Johnson & Johnson, J.B. Hunt Transport Services, Citizens Financial Group, and Truist Financial
10:21am, Friday, 15'th Jul 2022 Zacks Investment Research
Synchrony Financial, Johnson & Johnson, J.B. Hunt Transport Services, Citizens Financial Group, and Truist Financial are part of Zacks top Analyst Blog.
Should Vanguard Russell 1000 Value ETF (VONV) Be on Your Investing Radar?
10:20am, Friday, 15'th Jul 2022 Zacks Investment Research
Style Box ETF report for VONV
These 3 Blue-Chip Stocks Are Great Shields for Volatility
06:06pm, Thursday, 14'th Jul 2022 Zacks Investment Research
Investing in blue-chip stocks is a great way to add a higher level of defense to a portfolio. After all, defense wins ballgames.
